Introduction
============

Multiple inflammatory diseases, including RA ([@B50]), AD ([@B1]), seriously endanger human health. It is well accepted that inflammation is linked with oxidative stress. Oxidative stress refers to elevated intracellular levels of ROS that is considered to be the most potent inflammatory mediators ([@B62]). Antioxidants play a significant role in reducing inflammation ([@B72]). The activation of nuclear factor erythroid 2-related factor 2 (Nrf2) pathway could inhibit the progression of inflammation ([@B74]). Nrf2-mediated antioxidant gene expression can reduce the macrophage M1 phenotype and ROS production ([@B38]). Since Nrf2 pathway plays a critical role in inflammation, Nrf2 activators has become a potential therapeutic strategy for numerous disorders ([@B14]), such as inflammatory disorders ([@B34]), cardiovascular diseases ([@B41]), neurodegenerative diseases ([@B31]), cancer ([@B64]), type 2 diabetes ([@B10]), chronic kidney disease ([@B56]) and multiple sclerosis ([@B25]). However, there are only very little Nrf2 activators in clinics. Tecfidera (dimethyl fumarate), a potent Nrf2 activator, has been approved for the treatment of multiple sclerosis ([@B25]), but long-term use of this drug can cause resistance and other side effects ([@B15]). So, the discovery of new and safer Nrf2 activator for clinical use has become an important task in drug discovery.

In recent years, the research showed that natural components extracted from plant have anti-inflammatory and antioxidant effects ([@B61]). The roots and rhizomes of *Nardostachys chinensis* have been used for blood disorders, herpes and infection ([@B3]; [@B53]), the extracts of *N. chinensis* were also used for the treatment of epilepsy and hysteria ([@B4]). Above all, *N. chinensis* have neuroprotection and cardiovascular protection properties. However, the action mechanism of *N. chinensis* remains unclear. There are some studies reporting that the compounds isolated from *N. chinensis* suppressed LPS-induced activation of RAW264.7 cells ([@B29]; [@B63]). The activation of Nrf2-mediated antioxidant pathway has the neuroprotective effect ([@B7]) and antioxidant could promote anti-inflammatory effect ([@B42]).

Until now, the antioxidant activity of the compounds extracted from *N. chinensis* in macrophages remain unknown. Therefore, the anti-inflammatory activity and the antioxidant effect of Nardochinoid C (DC) (**Figure [1A](#F1){ref-type="fig"}**), a new compound with new skeleton isolated from *N. chinensi*s was studied for the first time in this research.

![The effect of Nardochinoid C (DC) on the release of NO and PGE~2~ in LPS-stimulated RAW264.7 cells. **(A)** The chemical structure of DC. **(B)** Cytotoxicity of DC on LPS-unstimulated RAW264.7 cells. **(C)** Cytotoxicity of DC on LPS-stimulated RAW264.7 cells. The cells were treated with DC at various concentrations (1.25--40 μM) for 1 h, and then stimulated with or without LPS for 18 h, the cell viability was analyzed with MTT method. Effects of DC on the productions of NO **(D)** and PGE~2~ **(E)** in LPS-stimulated RAW264.7 cells. The cells were incubated with indicated concentrations of DC or DEX for 1 h, and then stimulated with LPS for 18 h. The concentration of NO (expressed as nitrite) and PGE~2~ in the culture medium were quantified by ELISA kits. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests in GraphPad Prism7 (*P* \< 0.05, ANOVA). Results are expressed as mean ± SEM of three independent experiments (*N* = 3), ^\#^*p* \< 0.05, ^\#\#^*p* \< 0.01, vs. LPS-unstimulated cells **(B,C)** or ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. LPS-stimulated cells **(D,E)**.](fphar-09-00911-g001){#F1}

Macrophages play a key role in the innate immune response. It serves as the first line of defense in the body against invading pathogens and promotes cell protection and repair processes ([@B44]). Activated macrophage produces a variety of pro-inflammatory mediators, such as interleukin -6 (IL-6), tumor necrosis factor-α (TNF-α), prostaglandin E~2~ (PGE~2~), and nitric oxide (NO) ([@B51]; [@B33]; [@B69]), which can promote the development of inflammatory ([@B13]).

Therefore, two inflammatory cell models, LPS-stimulated RAW264.7 macrophage and LPS-stimulated THP-1 macrophage, were chosen to examine the anti-inflammatory activity of DC in this study.

We found that: (1) DC had significant anti-inflammatory activity both in LPS-induced RAW264.7 cells model and LPS-induced THP-1 cells model. (2) DC produced anti-inflammatory effect mainly through activating Nrf2/HO-1 pathway, rather than inhibiting NF-κB and MAPK pathways in LPS-stimulated RAW264.7 cell. (3) DC activated Nrf2 antioxidant pathways to reduce ROS production in LPS-stimulated RAW264.7 cell. (4) DC produced anti-inflammatory effect mainly through increasing the expression and the activity of HO-1 antioxidant protein.

These findings suggest that DC could be a new potential Nrf2 activator for the treatment and prevention of diseases related to inflammation and oxidative stress.

Materials and Methods {#s1}
=====================

Materials
---------

DC (HPLC purity \> 98%) was obtained from the Institute of Traditional Chinese Medicine and Natural Products, Jinan University. LPS, SFN, DEX, ZnPP, PMA, hemin, bilirubin, NADPH, glucose-6-phosphate, glucose-6-phosphate dehydrogenase and antibody to α-Tubulin were obtained from Sigma (St. Louis, MO, United States). LPS was first dissolved in PBS and then diluted with the medium to get the final working concentration. All the other test compounds (DEX, SFN, DC, ZnPP, and hemin) were first dissolved in DMSO and then diluted with the medium or potassium phosphate buffer to reach the final working concentration, respectively. The final concentration of DMSO was less than 0.1%. Antibodies to iNOS, COX-2, p-IKKα/β, p-p65, IKKα/β, p65, p-JNK, p-ERK, p-p38, JNK, ERK, p38, Nrf2, and Keap1 were from Cell Signaling Technology (Boston, MA, United States). Antibodies to p62, HO-1 and NQO-1 were from Abcam (Abcam, Cambridge, United Kingdom). Griess reagent from Promega (Promega, United States). ELISA kit for PGE~2~ were from Cayman Chemical (Cayman Chemical, Ann Arbor, MI, United States), ELISA kits for IL-6 and TNF-α were from eBioscience (eBioscience, Inc., United States). siRNA for Nrf2 (sc-37049), non-specific siRNA (sc-37007) and antibody to β-actin were from Santa Cruz Biotechnology (Santa Cruz, CA, United States). Lipofectamine 2000 (Lipo2000) was obtained from Invitrogen (Carlsbad, CA, United States). The secondary antibodies for Western blot were from Li-COR Biotechnology (Lincoln, NE, United States).

Cell Culture
------------

The RAW264.7 cells were from American Type Culture Collection (ATCC, Manassas, VA, United States). The cells were retained in Dulbecco's modified Eagle's medium (DMEM), which contained [L]{.smallcaps}-glutamine (2 mM), penicillin G (100 U/ml), 10% heat-inactivated FBS and streptomycin (100 mg/ml). The cells were incubated in a cell incubator remained at 37°C and a relative humidity of about 95% with 5% CO~2~. Conventional cell subculture by trypsinizing cells for 1--2 min. The cells before the 30th generation were taken for experimental research.

THP-1 human monocytic leukemia cells were from ATCC. The cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum and antibiotics. THP-1 cells were treated with 50 nM PMA (Sigma-Aldrich, St. Louis, MO, United States) for 48 h to induce differentiation of the cells into macrophages. Following differentiation, non-attached cells were removed by aspiration. The adherent macrophages were then washed three times with RPMI 1640 medium and maintained in a 37°C humidified incubator containing 5% CO~2~. The cells before the 30th generation were used for the experiments.

Cytotoxicity Assay
------------------

Cell viability was determined by MTT assay. Briefly, RAW264.7 cells were seeded in a 96-well tissue culture plate at a density of 1.4 × 10^4^ cells/well and incubated for 24 h, and then exposed to DC at various concentrations (1.25, 2.5, 5, 10, and 20 μM) for 18 h with or without LPS (100 ng/mL). THP-1 derived macrophages were seeded in a 96-well tissue culture plate at a density of 5 × 10^4^ cells/well and incubated with various concentrations (1.25, 2.5, 5, 10, and 20 μM) of DC for 24 h with or without LPS (1 μg/mL). Then, each well was added 10 μL of MTT solution (5 g/L) respectively, incubated at 37°C for 4 h, and then added 100 μL of 10% SDS-HCl solution. At last, the optical density of each well was determined at 570 nm (the reference wavelength was 650 nm).

Measurement of NO, PGE~2~, TNF-α, and IL-6
------------------------------------------

RAW264.7 cells were seeded in a 24 well plate at a density of 8 × 10^4^ cells/well and incubated for 24 h. The cells were then pretreated with DC for 1 h, and next exposed to LPS (100 ng/mL) for 18 h. THP-1 derived macrophages (1 × 10^6^ cells/well) were seeded in 6 well plates and incubated with various concentrations (2.5, 5, and 10 μM) of DC or DEX (0.5 μM) for 1 h, finally, exposed to LPS (1 μg/mL) for 24 h.

The cell supernatant of each well was collected, respectively, for detecting the concentration of PGE~2~, TNF-α, and IL-6 with the ELISA kits according to the manufacturer's instructions. Detection of NO content is based on Griess Reagent System (Promega, United States) according to the kit instructions.

Real-Time PCR Analysis
----------------------

RAW264.7 cells were seeded at a density of 8 × 10^4^ cells/well, and then incubated for 24 h. The cells were pretreated with various concentrations (2.5, 5, and 10 μM) of DC for 1 h, and then exposed to LPS (100 ng/mL) for 18 h. THP-1 derived macrophages (1 × 10^6^ cells/well) were seeded in 6 well plates and incubated with various concentration (2.5, 5, and 10 μM) of DC or DEX (0.5 μM) for 1 h, finally, exposed to LPS (1 μg/mL) for 24 h.

Total RNA was extracted from the cells by using the RNeasy Mini Kit (Qiagen, Germany). One microgram of total RNA was synthesized into cDNA by using the cDNA kit from Roche (Roche, Mannheim, Germany). Target RNA levels were determined by using ViiATM 7 real-time PCR.

PCR reaction system included 1 μl cDNA, 10 μl SYBR Green PCR Master Mix (Roche, Mannheim, Germany), 2 μl primers and 7 μl PCR-grade water. The reactions were performed with a denaturation step at 95°C for 10 min, 40 cycles of 95°C for 15 s and 60°C for 1 min. The relative mRNA expression levels were normalized to that of the internal control, using the 2^-ΔΔ^*^C^*^t^ cycle threshold method.

The gene relative expression for target gene were first normalized with internal reference gene (β-actin or GAPDH) and then the relative expression level of target gene for each test group were normalized with control group value. This explain why the value in the control group was 1. Therefore, the value for the normal control group was always 1 unit for each independent experiment and there is no SEM for the control group. The primers used in this study were listed in **Tables [1](#T1){ref-type="table"}**, **[2](#T2){ref-type="table"}**, respectively.

###### 

The primers for real time PCR of RAW264.7 cells.

  Target gene   Primer sequences
  ------------- --------------------------------
  β-actin_F     5′-CGGTTCCGATGCCCTGAGGCTCTT-3′
  β-actin_R     5′-CGTCACACTTCATGATGGAATTGA-3′
  iNOS_F        5′-CAGCACAGGAAATGTTTCAGC-3′
  iNOS_R        5′-TAGCCAGCGTACCGGATGA-3′
  COX-2_F       5′-TTTGGTCTGGTGCCTGGTC-3′
  COX-2_R       5′-CTGCTGGTTTGGAATAGTTGCTC-3′
  TNF-α_F       5′-TATGGCTCAGGGTCCAACTC-3′
  TNF-α_R       5′-CTCCCTTTGCAGAACTCAGG-3′
  IL-6_F        5′-GGTGACAACCACGGCCTTCCC-3′
  IL-6_R        5′-AAGCCTCCGACTTGTGAAGTGGT-3′
  Nrf2_F        5′-AGCAGGACATGGAGCAAGTT-3′
  Nrf2_R        5′-TTCTTTTTCCAGCGAGGAGA-3′
  HO-1_F        5′-CCCACCAAGTTCAAACAGCTC-3′
  HO-1_R        5′-AGGAAGGCGGTCTTAGCCTC-3′
  NQO1_F        5′-TTCTGTGGCTTCCAGGTCTT-3′
  NQO1_R        5′-AGGCTGCTTGGAGCAAAATA-3′
                

###### 

The primers for real time PCR of THP-1 cells.

  Target gene   Primer sequences
  ------------- -------------------------------
  GAPDH_F       5′- ACCAGCCTCAAGATCATCAGCA-3′
  GAPDH_R       5′- TGCTAAGCAGTTGGTGGTGC-3′
  TNF-α_F       5′- GCCCAGGCAGTCAGATCATC-3′
  TNF-α_R       5′- CGGTTCAGCCACTGGAGCT-3′
  IL-6_F        5′- GTGTTGCCTGCTGCCTTC-3′
  IL-6_R        5′- AGTGCCTCTTTGCTGCTTTC-3′
                

Protein Preparation and Western Blot Analysis
---------------------------------------------

RAW264.7 cells (8 × 10^4^ cells/well) were seeded in 24 well plates. After being incubated for 24 h, the cells were treated with various concentrations (2.5, 5, and 10 μM) of DC, DEX (0.5 μM) or SFN (10 μM) for 1 h, then exposed to LPS (100 ng/mL) for 6 h or 18 h. THP-1 derived macrophages (1 × 10^6^ cells/well) were seeded in 6 well plates and incubated with various concentration (2.5, 5, and 10 μM) of DC or DEX (0.5 μM) for 1 h, finally, exposed to LPS (1 μg/mL) for 24 h.

The cells were lysed using RIPA lysis buffer and the protein concentration was detected, respectively, by using the Bradford Assay Reagent (Bio-Rad, Philadelphia, PA, United States). The nuclear and cytoplasmic protein fractions were extracted by using NE-PER nuclear and cytoplasmic extraction kit (Thermo, Pierce, United States). Equal amounts of proteins were then separated by SDS-PAGE and transferred to a nitrocellulose membrane, the membrane was blocked by using 5% BSA solution, then incubated with the corresponding primary antibody for overnight at 4°C. Then, the membranes were incubated with the secondary antibodies for 1 h at 24°C. The band of antigen-antibody complexes were scanned by using the Odyssey CLx Imager (Li-COR, United States). Western blot data were analyzed by using ImageJ software. The image densities of specific bands for target protein were first normalized with the density of loading control reference protein band (β-actin or α-tubulin). Then, the relative expression level of target protein for each test group were normalized with the control group value. This explain why the value in the control group was 1. Therefore, the value for the normal control group was always 1 unit for each independent experiment and there is no SEM for the control group.

Immunofluorescence Analysis
---------------------------

For immunofluorescence analysis, RAW264.7 cells were seeded on glass coverslip in a six-well plate at a density of 2 × 10^5^ cells/well, and then incubated overnight. After being treated with 10 μM DC or SFN for 6 h, the cells were fixed with 4% paraformaldehyde for 30 min at room temperature, and subsequently permeabilized with 0.1% Triton X-100 for 30 min and blocked with 5% BSA for 30 min. The cells were then incubated with Nrf2 antibody for overnight, next incubated with the secondary antibody (Alexa Fluor 488-conjugated secondary antibody) for 1 h. At last, the cells were stained with DAPI for 5 min. The fluorescence images were captured by using a Leica TCS SP8 Confocal Laser Scanning Microscope System (Leica, Wetzlar, Germany).

Flow Cytometric Analysis
------------------------

Reactive oxygen species induction and macrophage M1 subtype were detected by flow cytometry. The cells (3 × 10^5^ cells/well) were cultured in a six-well plate, incubated for 18 h and then treated with 10 μM DC for 1 h, followed by stimulation with LPS (100 ng/mL) for 6 h. The cells were collected and stained for F/480 and CD11c to detect macrophage M1 subtype according to the manufacturer's directions (BioLegend, San Diego, CA, United States) or stained with the fluorescent probe DCFH-DA to determine ROS level according to the manufacturer's directions (Invitrogen, Carlsbad, CA, United States).

Transfection Assay
------------------

Nrf2 siRNA and non-specific siRNA (NS siRNA) were transfected into RAW264.7 cells by using lipofectamine 2000 reagent according to the manufacturer's directions. In brief, the cells were seeded in a 24-well culture plate and incubated with the NS siRNA or Nrf2 siRNA at 300 nM for 24--48 h in serum-free OPTI-MEM media (Invitrogen, United States). After incubation, the transfected cells were pretreated with indicated concentration of DC for 1 h and stimulated with or without LPS (100 ng/ml) for 18 h. The cells were prepared and the expressions of Nrf2 and HO-1 were analyzed by real-time PCR and Western blot analysis.

Measurement of Heme Oxygenase Activity
--------------------------------------

Heme oxygenase activity was determined by the production of bilirubin. The production of bilirubin from hemin was determined upon addition of rat-liver cytosol as the source of biliverdin reductase ([@B65]) with some modifications. Briefly, after the incubation, RAW264.7 macrophages were washed with PBS. Harvested cells were sonicated and centrifuged (18,000 × *g*, 10 min, 4°C). The supernatant (400 μl) was re-suspended in ice-cold potassium phosphate buffer (100 mM), then was added to a NADPH-generating system in 200 μl of reaction mixture containing 2 mg rat liver cytosol, 20 μM hemin, 1 mM NADPH, 2 mM glucose-6-phosphate, and 0.2 unit glucose-6-phosphate dehydrogenase in 100 mM potassium phosphate buffer, pH 7.4, at 37°C for 1 h. Bilirubin was then extracted with 1 ml chloroform and measured by the absorbance difference between 464 and 530 nm (extinction coefficient, 40 mM^-1^ cm^-1^ for bilirubin). HO-1 activity was expressed as nanomoles of bilirubin formed per mg of cell protein per hour.

Statistical Analysis
--------------------

The results were expressed as mean ± SEM and represented three independent experiments. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests or unpaired *t*-test in GraphPad Prism7. *P* \< 0.05 were considered statistically significant.

Results
=======

Nardochinoid C Reduced the Production of NO and PGE~2~ in LPS-Stimulated Macrophages
------------------------------------------------------------------------------------

The MTT results showed that DC at 1.25--10 μM concentrations was non-toxic to RAW264.7 cells with or without LPS stimulation (**Figures [1B,C](#F1){ref-type="fig"}**). Based on these results, 2.5--10 μM DC were selected to study the anti-inflammatory activity. When the cells were exposed to LPS for 18 h, the production of NO in the cell supernatant was significantly increased (*P* \< 0.01). DC obviously reduced the NO production induced by LPS in a concentration-dependent manner (*P* \< 0.05, **Figure [1D](#F1){ref-type="fig"}**). Pretreatment with DC for 1 h also obviously and concentration-dependently reduced the production of PGE~2~ induced by LPS in LPS-stimulated RAW264.7 cells (*P* \< 0.05, **Figure [1E](#F1){ref-type="fig"}**). DEX is a classic anti-inflammatory drug that significantly inhibits the release of inflammatory indicators ([@B37]), therefore, it was selected as a positive control to evaluate the anti-inflammatory activity of DC in this study. As shown in **Figures [1D,E](#F1){ref-type="fig"}**, the levels of NO and PGE~2~ were also significantly reduced by DEX (*P* \< 0.01).

Nardochinoid C Suppressed the Expression of iNOS, COX-2, TNF-α, and IL-6 in LPS-Stimulated RAW264.7 Macrophages
---------------------------------------------------------------------------------------------------------------

In the inflammatory response, NO and PGE~2~ are synthesized by inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), respectively ([@B73]; [@B59]). **Figures [2A,B](#F2){ref-type="fig"}** showed that iNOS and COX-2 proteins were increased in LPS treatment group, while DC pre-treatment obviously and concentration-dependently decreased the elevated expression levels of iNOS and COX-2 proteins, and DEX also inhibited the expressions of iNOS and COX-2 proteins (*P* \< 0.05∼0.01, **Figures [2A,B](#F2){ref-type="fig"}**).

![Effects of DC on the expressions of iNOS, COX-2, TNF-α, and IL-6 in LPS-stimulated RAW264.7 cells. The cells were plated in 24-well plates and incubated for 24 h, next the cells were pretreated with indicated concentrations of DC for 1 h and stimulated with LPS for 18 h. The total proteins of the cells were prepared and the expressions of iNOS **(A)** and COX-2 **(B)** were analyzed by Western blot. Total mRNA was prepared, the mRNA expressions of iNOS **(C)** and COX-2 **(D)** were analyzed by real time PCR. The protein expression levels of TNF-α **(E)** and IL-6 **(F)** in cell supernatant were analyzed by ELISA. The mRNA expression of TNF-α **(G)** and IL-6 **(H)** were analyzed by real time PCR. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests in GraphPad Prism7 (*P* \< 0.05, ANOVA). Results are expressed as mean ± SEM of three independent experiments (*N* = 3). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. LPS-stimulated cells.](fphar-09-00911-g002){#F2}

As shown in **Figures [2C,D](#F2){ref-type="fig"}**, LPS stimulation increased the mRNA levels of iNOS and COX-2, DC pre-treatment obviously and concentration-dependently decreased the elevated mRNA levels of iNOS and COX-2, and DEX also showed inhibitory effects similar to DC (*P* \< 0.05 ∼ 0.01).

When inflammation occurs, activated macrophages acts as the major effector cells that secrete large amounts of inflammatory mediators (e.g., TNF-α and IL-6) to promote the development and progression of inflammation ([@B21]). Therefore, these related inflammatory mediators, including TNF-α and IL-6 were detected in this study. As shown in **Figures [2E,F](#F2){ref-type="fig"}**, LPS stimulation increased the protein levels of TNF-α and IL-6, while the increased protein levels of TNF-α and IL-6 were both significantly inhibited by DC in a concentration-dependent manner and by DEX (*P* \< 0.05 ∼ 0.01). LPS stimulation also increased the mRNA levels of TNF-α and IL-6 (**Figures [2G,H](#F2){ref-type="fig"}**), while these increases were significantly inhibited by DC concentration dependently and by DEX (*P* \< 0.05 ∼ 0.01, **Figures [2G,H](#F2){ref-type="fig"}**).

Nardochinoid C Suppressed the Levels of COX-2, PGE~2~, TNF-α, and IL-6 in LPS-Stimulated THP-1 Macrophages
----------------------------------------------------------------------------------------------------------

The MTT results showed that DC at 1.25--10 μM concentrations was non-toxic to THP-1 cells with or without LPS stimulation (**Figures [3A,B](#F3){ref-type="fig"}**). Based on these results, 2.5--10 μM DC were selected to study the anti-inflammatory activity in LPS-stimulated THP-1 macrophages.

![Effects of DC on the levels of COX-2, PGE~2~, TNF-α, and IL-6 in LPS-stimulated THP-1 cells. **(A)** Cytotoxicity of DC on LPS-unstimulated THP-1 cells. **(B)** Cytotoxicity of DC on LPS-stimulated THP-1 cells. **(C)** Effects of DC on the expression of COX-2 in LPS-stimulated THP-1 cells. **(D)** Effects of DC on the productions of PGE~2~ in LPS-stimulated THP-1 cells. The mRNA expression of TNF-α **(E)** and IL-6 **(F)** were analyzed by real time PCR. THP-1 cells (1 × 10^6^ cells/well) were seeded in six well plates. After being incubated for 24 h, the cells were treated with 50 nM PMA for 48 h, then incubated with various concentration (2.5, 5, and 10 μM) of DC or DEX (0.5 μM) for 1 h, finally, exposed to LPS (1 μg/mL) for 24 h. The cell supernatant, total proteins and mRNA of the cells were prepared as described before for Western blot and real time PCR. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests in GraphPad Prism7 (*P* \< 0.05, ANOVA). Results are expressed as mean ± SEM of three independent experiments (*N* = 3). ^\#^*p* \< 0.05, ^\#\#^*p* \< 0.01, vs. LPS-unstimulated cells **(A,B)** or ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. LPS-stimulated cells **(C--F)**.](fphar-09-00911-g003){#F3}

**Figure [3C](#F3){ref-type="fig"}** showed that COX-2 proteins were increased in LPS treatment group, while DC pre-treatment obviously and concentration-dependently decreased the elevated expression levels of COX-2 proteins (*P* \< 0.05 ∼ 0.01, **Figure [3C](#F3){ref-type="fig"}**).

When the cells were exposed to LPS for 24 h, the production of PGE~2~ in the cell supernatant was significantly increased (*P* \< 0.01). DC obviously reduced the PGE~2~ production induced by LPS in a concentration-dependent manner (*P* \< 0.05, **Figure [3D](#F3){ref-type="fig"}**). As shown in **Figures [3C,D](#F3){ref-type="fig"}**, the levels of COX-2 and PGE~2~ were also significantly reduced by DEX (*P* \< 0.01).

As shown in **Figures [3E,F](#F3){ref-type="fig"}**, LPS stimulation also increased the mRNA levels of TNF-α and IL-6 in THP-1 cells model, while these increases were significantly inhibited by DC concentration dependently and DEX (*P* \< 0.05 ∼ 0.01, **Figures [3E,F](#F3){ref-type="fig"}**).

Nardochinoid C Failed to Inhibit the Activation of NF-κB and MAPK Pathway in LPS-Stimulated RAW264.7 Macrophages
----------------------------------------------------------------------------------------------------------------

Nuclear factor-κB (NF-κB) pathway is activated in inflammatory process and then promotes the expression of inflammatory mediators in different cells, including macrophages ([@B16]). LPS activates NF-κB pathway to induce the production of inflammatory cytokines ([@B23]). MAPK pathway also plays an critical role in inflammatory response ([@B47]). The activation of NF-κB and MAPK signaling pathways are both involved in the development of inflammation ([@B46]). Therefore, the inhibition of NF-κB and MAPK signaling pathways are considered as the useful ways to regulate inflammatory reaction. In the non-inflammatory condition, NF-κB and IκBα are present in the cytoplasm as complex ([@B58]). The activation of NF-κB resulted in the phosphorylation of IKKα/β, p65, and then leading to the transcription of inflammatory genes and the expression of inflammatory proteins ([@B24]).

As **Figure [4A](#F4){ref-type="fig"}** shows, LPS stimulation increased the phosphorylation of IKKα/β and p65. However, DC failed to inhibit the phosphorylation of these proteins (**Figure [4A](#F4){ref-type="fig"}**). LPS also increased the nuclear translocation of NF-κB p65 protein, but the pretreatment of DC failed to inhibit the nuclear translocation of NF-κB p65 induced by LPS (**Figure [4B](#F4){ref-type="fig"}**). MAPKs activation involves in regulating inflammation process ([@B32]). The activation of MAPK pathway resulted in the phosphorylation of p38, JNK and ERK ([@B54]), which may promote pro-inflammatory cytokines production ([@B67]). The results showed that LPS increased the protein levels of p-JNK, p-p38 and p-ERK (**Figure [4C](#F4){ref-type="fig"}**), but DC pretreatment didn't inhibit the increased levels of p-JNK, p-p38 and p-ERK proteins induced by LPS (**Figure [4C](#F4){ref-type="fig"}**).

![The effect of DC on the activation of NF-κB and MAPK pathways in LPS-stimulated RAW264.7 cells. The cells were plated in 24-well plates and incubated for 24 h, next the cells were pretreated with indicated concentration of DC for 1 h and stimulated with LPS for 15 min. The total proteins of the cells were prepared and the expression of phosphorylation level of IKKα/β and p65 **(A)** were detected by Western blot. The cells were treated with DC (10 μM) for 1 h and stimulated with LPS for 15 min. The subcellular localization of p65 was detected with immunofluorescence assay **(B)** and the images were acquired using the Leica DM2500 fluorescent microscopy. The total proteins of the cells were prepared and the expressions of phosphorylated JNK, ERK and p38 **(C)** were detected by Western blot.](fphar-09-00911-g004){#F4}

Nardochinoid C Attenuated LPS-Induced M1 Phenotype and ROS Generation and Also Increased the Levels of HO-1 and NQO1 in LPS-Stimulated RAW264.7 Macrophages
-----------------------------------------------------------------------------------------------------------------------------------------------------------

Previous reports showed that Nrf2-mediated antioxidant gene expression reduced the M1 phenotype and ROS production and contributed to anti-inflammation ([@B38]). Macrophages could polarize to M1 phenotype under an inflammatory environment ([@B30]). As shown in **Figure [5A](#F5){ref-type="fig"}**, LPS induced an increase of macrophages in M1 phenotype and DC pretreatment at 10 μM suppressed this increase (*P* \< 0.05). ROS participates in inflammation ([@B75]), the activation of Nrf2 could decrease the levels of ROS ([@B68]). As shown in **Figure [5B](#F5){ref-type="fig"}**, intracellular ROS was increased by LPS stimulation and DC pretreatment at 10 μM also suppressed the ROS generation induced by LPS (*P* \< 0.05).

![The effect of DC on the expressions of M1, ROS, HO-1, and NQO1 in LPS-stimulated RAW264.7 cells. RAW264.7 cells were pretreated with indicated concentrations of DC for 1 h, then cells were incubated for 6 h in the absence of LPS, then collected all the cells and cellular staining for F/480 and CD11c, the M1 markers **(A)** according to the manufacturer's directions. The intracellular level of ROS **(B)** was determined using the fluorescent probe DCFH-DA. The cells were plated in 24-well plates and incubated for 24 h, next the cells were pretreated with indicated concentrations of DC for 1 h and stimulated with LPS for 18 h. The total proteins of the cells were prepared and the expression of HO-1 **(C)** and NQO1 **(D)** were analyzed by Western blot. The mRNA expressions of HO-1 **(E)** and NQO1 **(F)** were analyzed by real time PCR. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests in GraphPad Prism7 (*P* \< 0.05, ANOVA). Results are expressed as mean ± SEM of three independent experiments (*N* = 3). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. LPS-stimulated cells.](fphar-09-00911-g005){#F5}

Nrf2 dimerizes with small Maf proteins in the nucleus, and then binds *cis*-oxidation reaction elements, i.e., HO-1 and NQO1, to activate their transcription ([@B6]; [@B27]). Antioxidant protein HO-1 has anti-oxidative and anti-inflammatory effects ([@B45]; [@B50]). Many studies have shown that defective expression of HO-1 in humans is accompanied by an increase in the inflammatory state ([@B52]). Nrf2 also could increase the transcription of its target genes, including HO-1 and NQO1 ([@B28]). In order to understand whether DC could exert its anti-inflammatory effect through activating Nrf2 pathway, the downstream proteins (HO-1 and NQO1) of Nrf2 pathway were investigated in this study. As shown in **Figures [5C](#F5){ref-type="fig"}--[F](#F5){ref-type="fig"}**, compared with LPS-stimulated RAW264.7 cell, DC concentration-dependently increased the levels of NQO1 and HO-1 proteins (*P* \< 0.05 ∼ 0.01, **Figures [5C,D](#F5){ref-type="fig"}**) and the expressions of NQO1 and HO-1 mRNA (*P* \< 0.05, **Figures [5E,F](#F5){ref-type="fig"}**). However, DEX have no obvious influence on the protein and mRNA levels of NQO1 and HO-1, compared with LPS group (**Figures [5C](#F5){ref-type="fig"}--[F](#F5){ref-type="fig"}**).

Nardochinoid C Promoted the Nucleus Translocation of Nrf2 Protein and Activated Nrf2 Pathway by Inhibiting Keap1 in LPS-Unstimulated RAW264.7 Macrophages
---------------------------------------------------------------------------------------------------------------------------------------------------------

Above studies have showed that DC increased the protein levels of HO-1 and NQO1 in LPS-stimulated RAW264.7 cells. Next, the effects of DC on Nrf2 pathway in LPS-unstimulated RAW264.7 cells were also investigated. SFN, a potent Nrf2 activator ([@B18]), was selected as a positive control. As shown in **Figures [6A,B](#F6){ref-type="fig"}**, pretreatment of DC at 10 μM significantly promoted Nrf2 protein entering into the nucleus in RAW264.7 cells, this is similar to SFN (*P* \< 0.01). DC or SFN pretreatment both increased the level of NQO1 and HO-1 proteins (*P* \< 0.05 ∼ 0.01, **Figures [6C,D](#F6){ref-type="fig"}**) and the expressions of NQO1 and HO-1 mRNA (*P* \< 0.05, **Figures [6E,F](#F6){ref-type="fig"}**) in unstimulated RAW264.7 cell. Keap1 is a negative regulator of the transcription factor Nrf2 ([@B60]). Recently, p62 was thought to be an upstream protein of Nrf2 ([@B39]). **Figures [6G,H](#F6){ref-type="fig"}** show that DC decreased Keap1 protein expression in a concentration-dependent manner but didn't promote p62 protein expression in LPS-unstimulated RAW264.7 macrophages.

![The effect of DC on the nuclear translocation of Nrf2 and the expressions of HO-1, NQO1, Keap1, and p62 in LPS-unstimulated RAW264.7 cells. The cells were treated with SFN or DC (10 μM) for 6 h. The subcellular localization of Nrf2 was detected with immunofluorescence assay **(A)** and the images were acquired using the Leica DM2500 fluorescent microscopy. The nuclear protein of the cells was prepared and the expression of Nrf2 in nuclear protein **(B)** of the cells were analyzed by Western blot. The cells were plated in 24-well plates and incubated for 24 h, next the cells were pretreated with indicated concentrations of DC for 1 h and stimulated with or without LPS for 18 h. The total proteins of the cells were prepared and the expressions of HO-1 **(C)**, NQO1 **(D)**, Keap1 **(G)**, and p62 **(H)** were analyzed by Western blot. The mRNA levels of HO-1 **(E)** and NQO1 **(F)** were analyzed by real time PCR. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests in GraphPad Prism7 (*P* \< 0.05, ANOVA). Results are expressed as mean ± SEM of three independent experiments (*N* = 3). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. LPS-unstimulated cells.](fphar-09-00911-g006){#F6}

Nrf2 siRNA and HO-1 Inhibitor Significantly Abolished the Effect of Nardochinoid C
----------------------------------------------------------------------------------

To further demonstrate the contribution of Nrf2 signaling pathway to the anti-inflammatory effect of DC, Nrf2 gene knockdown model was established by using Nrf2 siRNA transfection in RAW264.7 cells. The results showed that the protein and mRNA expressions of Nrf2 were significantly suppressed by using specific Nrf2 siRNA (**Figures [7A,B](#F7){ref-type="fig"}**). The increases in Nrf2 and HO-1 at protein levels caused by DC pretreatment at 10 μM were significantly suppressed by Nrf2 siRNA (**Figures [7C](#F7){ref-type="fig"}--[F](#F7){ref-type="fig"}**). The suppressive effect of DC on NO production was also abolished by Nrf2 siRNA (**Figure [7G](#F7){ref-type="fig"}**). These results indicated that the expression of antioxidant proteins HO-1 mediated the anti-inflammatory effect of DC.

![The effect of Nrf2 siRNA and HO-1 inhibitor on the anti-inflammatory effect of DC. For transfection, the cells were seeded in 24-well culture plates and incubated with the control siRNA or Nrf2 siRNA at 300 nM for 24--48 h in serum-free OPTI-MEM media. The total proteins of Nrf2 **(A)** were analyzed by Western blot. The mRNA level of Nrf2 **(B)** were analyzed by real time PCR. Statistical analysis was carried out by using unpaired *t*-test in GraphPad Prism7 (*P* \< 0.05, unpaired *t*-test). Results are expressed as mean ± SEM of three independent experiments (*N* = 3). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. NS siRNA treated cells **(B)**. The transfected cells were also pretreated with indicated concentration of DC for 1 h and stimulated with or without LPS for 18 h. The total proteins of the cells were prepared and the expressions of Nrf2 **(C,E)** and HO-1 **(D,F)** were analyzed by Western blot. The concentration of NO **(G)** in the culture medium were quantified. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests in GraphPad Prism7 (*P* \< 0.05, ANOVA). Results are expressed as mean ± SEM of three independent experiments (*N* = 3). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. DC, LPS, and NS siRNA treated cells **(E--G)**.](fphar-09-00911-g007){#F7}

In this study, we found that DC decreased the expression of iNOS (**Figure [8A](#F8){ref-type="fig"}**) and the release of NO (**Figure [8C](#F8){ref-type="fig"}**). ZnPP, the inhibitor of HO-1 activity ([@B36]), significantly reversed the effect of DC on HO-1 protein activity (**Figure [8D](#F8){ref-type="fig"}**) rather than HO-1 expression (**Figure [8B](#F8){ref-type="fig"}**) to reverse the effect of DC on the expression of iNOS (**Figure [8A](#F8){ref-type="fig"}**) and the release of NO (**Figure [8B](#F8){ref-type="fig"}**).

![The effect of HO-1 inhibitor on the anti-inflammatory effect of DC. The cells were pretreated with indicated concentration of ZnPP for 1 h, and then stimulated with DC for 1 h, at last, treated with LPS for 18 h. The total proteins of iNOS **(A)**, and HO-1 **(B)** were analyzed by Western blot. The concentration of NO **(C)** in the culture medium were quantified. The levels of Bilirubin **(D)** in cell microsome fraction were detected. Statistical analysis was carried out by using one-way ANOVA with Tukey's multiple comparison tests in GraphPad Prism7 (*P* \< 0.05, ANOVA). Results are expressed as mean ± SEM of three independent experiments (*N* = 3). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, vs. LPS treated cells, ^\#^*p* \< 0.05 vs. ZnPP treated cells.](fphar-09-00911-g008){#F8}

Discussion
==========

When inflammation occurs, activated macrophages release a large number of different inflammatory mediators (NO, PGE~2~, TNF-α, and IL-6) and regulatory enzymes (iNOS and COX-2) ([@B45]; [@B11]; [@B50]; [@B5]). In this research, LPS stimulation elevated the levels of these inflammatory mediators (NO, PGE~2~, TNF-α, and IL-6) and regulatory enzymes (iNOS and COX-2), but the increases of these inflammatory mediators and regulatory enzymes were significantly inhibited by DC (**Figures [1](#F1){ref-type="fig"}**, **[2](#F2){ref-type="fig"}**), implying that DC has obvious anti-inflammatory activity in LPS-stimulated RAW264.7 macrophage cells model.

THP-1 cell line was used to estimate modulation of monocyte and macrophage activities ([@B9]). In this study, we also use LPS-stimulated THP-1 macrophages to study the anti-inflammatory activity of DC. Our results showed that LPS stimulation elevated the levels of inflammatory protein (COX-2), inflammatory mediators (PGE~2~) and inflammatory genes (TNF-α and IL-6), but these increases were significantly inhibited by DC (**Figures [3D,E](#F3){ref-type="fig"}**), implying that DC also has obvious anti-inflammatory activity in LPS-stimulated THP-1 macrophages, these effects are similar to these in LPS-stimulated RAW264.7 macrophages.

In LPS-stimulated THP-1 cell model, we did not detect the high expressed iNOS gene (data not shown), which is similar to the paper reported that LPS could not up-regulated iNOS gene in THP-1 macrophages ([@B8]). There is no doubt that iNOS is an important inflammatory index, it is expressed in response to a variety of inflammatory stimuli and generates NO in macrophage during the inflammatory process ([@B40]), the inhibition of iNOS was able to reduce the production of ROS ([@B17]). As described earlier, ROS play an important role in oxidative stress and inflammatory responses. LPS-stimulated THP-1 macrophages without the high expressed iNOS gene, so in the next study, we selected the commonly used inflammatory model, LPS-stimulated RAW264.7 macrophages which expresses high levels of iNOS and ROS for in-depth study on the mechanisms underlying the anti-inflammatory effect of DC.

There were reports showing that the inhibition of LPS-induced NO, PGE~2~, iNOS, COX-2, TNF-α, and IL-6 through the inactivation of NF-κB and MAPK pathway in RAW264.7 cells ([@B35]; [@B46]). Other previous studies have introduced that the extracts of *N. chinensis* inhibited the production of inflammatory mediators through the inhibition of p38 MAPK pathway instead of the inhibition of NF-κB pathway. In order to study the anti-inflammatory mechanism of DC, the effects of DC on the activation of NF-κB and MAPK pathways in LPS-stimulated RAW264.7 cells were investigated, but the results suggested that DC didn't inhibit the activation of NF-κB and MAPK pathways (**Figures [4A](#F4){ref-type="fig"}--[C](#F4){ref-type="fig"}**), so DC may not act on NF-κB and MAPK pathways to exert its anti-inflammatory effects. This is common to other terpenoid- derived compounds with known anti-inflammatory effects ([@B19]; [@B48]).

It has been reported that the activation of Nrf2 anti-oxidant pathway prevents LPS-induced transcriptional upregulation of pro-inflammatory cytokines, including IL-6. Since the current results showed that DC inhibited IL-6 obviously (**Figure [2F](#F2){ref-type="fig"}**), so it was hypothesized that DC may activate Nrf2 pathway to exert its anti-inflammatory effect. As described before, Nrf2 pathway mediated antioxidant gene expression reduced the M1 phenotype and ROS production ([@B38]). In order to verify the hypothesis of this study, the M1 phenotype and ROS production in LPS-stimulated RAW264.7 cells were examined, the results showed that the elevated M1 phenotype and ROS production induced by LPS were significantly inhibited by DC (**Figures [5A,B](#F5){ref-type="fig"}**), suggesting that DC is likely to exert anti-inflammatory and anti-oxidant effects by activating the Nrf2 anti-oxidant pathway.

The Nrf2-dependent anti-oxidant genes HO-1 and NQO-1 could block TNF-α and IL-6 inflammatory mediators. In Nrf2-knockout mice, the anti-inflammatory effect disappeared ([@B70]). Nrf2-knockout mice showed increased mRNA and protein levels of COX-2, iNOS, IL-6, and TNF-α ([@B55]). Furthermore, the activation of Nrf2 leads to its nuclear translocation, resulting in the decrease of COX-2 and iNOS ([@B26]). In this study, it was found that DC inhibited the expressions of inflammatory proteins (COX-2 and iNOS, **Figures [2A,B](#F2){ref-type="fig"}**) and inflammatory cytokines (TNF-α and IL-6, **Figures [2E](#F2){ref-type="fig"}--[H](#F2){ref-type="fig"}**) accompanied by the increase of antioxidant proteins HO-1 and NQO1 (**Figures [5C](#F5){ref-type="fig"}--[F](#F5){ref-type="fig"}**). All of these results further indicated that DC may activate Nrf2 pathway to exert its anti-inflammatory effects.

In oxidative stress and inflammation condition, enhancement of HO-1 expression plays an important role in cell protection ([@B57]; [@B12]). HO-1 can be rapidly induced by various oxidative-inducing agents, also including LPS ([@B12]). The current results also showed that LPS increased the level of HO-1 slightly, but compared with LPS group, DC further increased the level of HO-1 protein dramatically (**Figures [5C,E](#F5){ref-type="fig"}**). The high expression of HO-1 can inhibit LPS-induced NO production ([@B43]). In this study, DC reduced NO production while increasing HO-1 expression (**Figures [1D](#F1){ref-type="fig"}**, **[5C,E](#F5){ref-type="fig"}**), the current results are consistent with that the high expression of HO-1 can inhibit LPS-induced NO production ([@B43]).

Sulforaphane is an known and potent Nrf2 activator and capable of preventing toxicity of organic chemicals ([@B18]) and has antioxidant protection effects ([@B22]). In the current study, DEX had strong anti-inflammatory activity, but didn't show any effect on the activation of Nrf2 pathway, implying that DEX produced its anti-inflammatory effect through a Nrf2 independent way. Therefore, SFN was chosen as a positive drug to evaluate the antioxidant activity and underlying mechanisms of DC related to Nrf2 pathway. The current research showed that both DC and SFN increased the levels of HO-1 and NQO1 in LPS-unstimulated RAW264.7 cell (**Figures [6C](#F6){ref-type="fig"}--[F](#F6){ref-type="fig"}**). Since DC increased the downstream antioxidant proteins (HO-1 and NQO1) of Nrf2 pathway, it was indicated that DC could also activate Nrf2 and make Nrf2 protein entering into the nucleus. In this research, we did find that DC increased the nuclear translocation of Nrf2 (**Figures [6A,B](#F6){ref-type="fig"}**), further supported that DC was able to activate Nrf2 pathway to promote the increase of antioxidant protein to reduce ROS production.

Keap1 is a negative regulator of the transcription factor Nrf2, which mediated the inactivation of Nrf2 and thus enhanced Nrf2 translocation into the nucleus ([@B60]; [@B49]). It has been reported that protein p62, which is on the upstream of Nrf2 pathway, can inactivate Keap1 and activate Nrf2 ([@B39]). The current research found that DC inhibited the expression of Keap1 (**Figure [6G](#F6){ref-type="fig"}**) but didn't increase p62 expression (**Figure [6H](#F6){ref-type="fig"}**), suggesting that DC induced Nrf2 activation probably through inhibiting Keap1 expression instead of upregulating p62 protein.

To further confirm the pivotal role of Nrf2 pathway in the anti-inflammatory effect of DC, Nrf2 siRNA was employed to down regulate the protein and gene expressions. The results showed that the mRNA and protein level of Nrf2 were significantly suppressed by using specific Nrf2 siRNA (**Figures [7A,B](#F7){ref-type="fig"}**). The protein expressions of Nrf2 and HO-1 were decreased by Nrf2 siRNA (**Figures [7C](#F7){ref-type="fig"}--[F](#F7){ref-type="fig"}**). The suppressive effect of DC on NO production induced by LPS was also abolished by Nrf2 siRNA (**Figure [7G](#F7){ref-type="fig"}**), these results suggested the anti-inflammatory effect of DC is mediated by the activation of Nrf2/HO-1 antioxidant pathway.

It has been reported in the literature ([@B66]) that increasing the activity of HO-1 can reduce the production of iNOS and NO. Bilirubin, the metabolic products of HO-1, also exerts anti-inflammatory effect ([@B2]). In order to further confirm the important role of HO-1 activity in mediating the anti-inflammatory effect of DC. ZnPP, a HO-1 activity inhibitor ([@B20]), was used in the research.

In this study, we found that DC increased the expression (**Figure [8B](#F8){ref-type="fig"}**) and the activity of HO-1 protein (**Figure [8D](#F8){ref-type="fig"}**). At the same time, DC decreased the expression of iNOS (**Figure [8A](#F8){ref-type="fig"}**) and the release of NO (**Figure [8C](#F8){ref-type="fig"}**). ZnPP significantly reversed the effect of DC on HO-1 protein activity (**Figure [8D](#F8){ref-type="fig"}**) rather than HO-1 expression (**Figure [8B](#F8){ref-type="fig"}**) to block the effect of DC on the expression of iNOS (**Figure [8A](#F8){ref-type="fig"}**) and the release of NO (**Figure [8C](#F8){ref-type="fig"}**), these results further confirmed that the anti-inflammatory effect of DC was mediated by the increase of HO-1 activity. In short, DC activates Nrf2/HO-1 pathway to increase anti-oxidant proteins, which in turn reduce inflammation and oxidative stress to contribute to its anti-inflammatory and antioxidant effects (**Figure [9](#F9){ref-type="fig"}**).

![Proposed molecular mechanisms underlying the inhibitory effect of DC on the activation of macrophage induced by LPS. DC activates Nrf2 pathway to increase anti-oxidant genes and protein, which in turn reduce inflammation and oxidative stress.](fphar-09-00911-g009){#F9}

Nrf2 activator can be used as potential therapies for numerous disorders ([@B14]), but there are very few Nrf2 activators applicable currently in clinics. In addition, the current available Nrf2 activator, dimethyl fumarate, has showed drug resistance and side effects ([@B15]). Therefore, there is significant need to develop new and safer Nrf2 activator for clinical use. In this research, DC exerted anti-inflammatory effects mainly through the activation of Nrf2 pathway. This implies that DC may be a new Nrf2 activator and has the potential to be developed as new drug. Nrf2 pathway plays an important role in oxidative stress response and metabolism, Nrf2 activation can significantly inhibit the onset of diabetes and prevent diabetes ([@B71]). Since DC also activates Nrf2 pathway in the absence of LPS, it indicated that DC could not only treat inflammation but also prevent many other diseases related to oxidative stress response and metabolism, giving broader application situations to this compound.

Conclusion
==========

Taken together, we discovered a novel Nrf2 activator, DC, which acts on Nrf2/HO-1 pathway to exert its anti-inflammatory effects against LPS-induced inflammation. Besides, the unique anti-inflammatory mechanism of DC may provide a new therapeutic window for the prevention and treatment of oxidative damage and inflammation-related diseases. Although other inflammation-related cell experiments, animal models and clinical trials are certainly needed to do in future depth research, this study now still could help providing a potential treatment mechanism of *N. chinensis* and also provide a novel natural compound with new skeleton for the treatment of the diseases related to inflammation and oxidative stress.
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